Literature DB >> 678400

The urinary excretion of phenelzine.

B Caddy, A H Stead, E C Johnstone.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1978        PMID： 678400      PMCID： PMC1429400          DOI： 10.1111/j.1365-2125.1978.tb00853.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN： 0306-5251            Impact factor:   4.335


× No keyword cloud information.
  4 in total

1.  Isoniazid and iproniazid: activation of metabolites to toxic intermediates in man and rat.

Authors:  S D Nelson; J R Mitchell; J A Timbrell; W R Snodgrass; G B Corcoran
Journal:  Science       Date:  1976-09-03       Impact factor: 47.728

2.  An improved and simplified method of detecting the acetylator phenotype.

Authors:  D A Evans
Journal:  J Med Genet       Date:  1969-12       Impact factor: 6.318

3.  Indirect determination of phenelzine in urine.

Authors:  B Caddy; A H Stead
Journal:  Analyst       Date:  1977-01       Impact factor: 4.616

4.  Metabolism of amphetamines. Identification of N-oxygenated products by gas chromatography and mass spectrometry.

Authors:  A H Beckett; R T Coutts; F A Ogunbona
Journal:  J Pharm Pharmacol       Date:  1973-09       Impact factor: 3.765
  4 in total
  3 in total

1.  Phenelzine: acetylator status and clinical response.

Authors:  G L Sanders; M D Rawlins
Journal:  Br J Clin Pharmacol       Date:  1979-05       Impact factor: 4.335

2.  Mitigation of sensory and motor deficits by acrolein scavenger phenelzine in a rat model of spinal cord contusive injury.

Authors:  Zhe Chen; Jonghyuck Park; Breanne Butler; Glen Acosta; Sasha Vega-Alvarez; Lingxing Zheng; Jonathan Tang; Robyn McCain; Wenpeng Zhang; Zheng Ouyang; Peng Cao; Riyi Shi
Journal:  J Neurochem       Date:  2016-05-16       Impact factor: 5.372

3.  The effect of acetylator phenotype on the disposition of aminoglutethimide.

Authors:  A M Adam; H J Rogers; S A Amiel; R D Rubens
Journal:  Br J Clin Pharmacol       Date:  1984-10       Impact factor: 4.335
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.